Overview
Reuven Schore, MD, is a pediatric oncologist and a member of the Leukemia/Lymphoma Program at Children's National Hospital. Dr. Schore is an associate professor, pediatrics at George Washington University School of Medicine. Dr. Schore is the vice chair for a Children's Oncology Group study investigating intravenous treatments for patients with high-risk acute lymphoblastic leukemia (ALL).
Dr. Schore is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Juvenile Myelomonocytic Leukemia (JMML), and Febrile Neutropenia.
Dr. Schore is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2006 and Pediatrics: American Board Of Pediatrics, 2003. He is actively involved in clinical research, co-authoring 41 peer reviewed articles and participating in 3 clinical trials.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
Locations
111 Michigan Avenue Northwest, Childrens National Telemedicine, Washington, DC 20010
9850 Key West Avenue, Rockville, MD 20850
111 Michigan Avenue Northwest, Washington, DC 20010
Additional Areas of Focus
Dr. Schore has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Children's National Hospital
Roger Packer is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Packer is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, and Gliomatosis Cerebri.
Children's National Hospital
Andrea Gropman is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Gropman is highly rated in 37 conditions, according to our data. Her clinical expertise encompasses Klinefelter Syndrome, Urea Cycle Disorders (UCD), MELAS Syndrome, Ornithine Transcarbamylase Deficiency, and Hormone Replacement Therapy (HRT).
Ozlem Goker-Alpan MD LLC
Ozlem Goker is a primary care provider, practicing in Pediatrics in Fairfax, Virginia. Dr. Goker is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Gaucher Disease, Fabry Disease, Gaucher Disease Type 1, and Pompe Disease.
Frequently Asked Questions about Dr. Reuven J. Schore
How do I make an appointment with Dr. Reuven J. Schore?
You can book an appointment with Dr. Reuven J. Schore by calling their office at 888-884-2327. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Reuven J. Schore a top-rated expert for Acute Lymphoblastic Leukemia (ALL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Reuven J. Schore is classified as an Distinguished expert for Acute Lymphoblastic Leukemia (ALL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Reuven J. Schore specialize in?
While Dr. Reuven J. Schore is a Pediatrics, they have specific expertise in Acute Lymphoblastic Leukemia (ALL), Leukemia, and Juvenile Myelomonocytic Leukemia (JMML). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.
Does Dr. Reuven J. Schore participate in research or clinical trials?
Yes. Dr. Reuven J. Schore has published 41 articles and abstracts on conditions like Acute Lymphoblastic Leukemia (ALL). You can view a list of Dr. Reuven J. Schore's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Reuven J. Schore accept my insurance?
Dr. Reuven J. Schore accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 888-884-2327 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Lymphoblastic Leukemia (ALL)Dr. Schore isDistinguished. Learn about Acute Lymphoblastic Leukemia (ALL).
- LeukemiaDr. Schore isDistinguished. Learn about Leukemia.
- Advanced
- Juvenile Myelomonocytic Leukemia (JMML)
- Experienced
- Acute Erythroid Leukemia (AEL)Dr. Schore isExperienced. Learn about Acute Erythroid Leukemia (AEL).
- Childhood Acute Myeloid LeukemiaDr. Schore isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Ewing SarcomaDr. Schore isExperienced. Learn about Ewing Sarcoma.
- Febrile NeutropeniaDr. Schore isExperienced. Learn about Febrile Neutropenia.
- Infantile NeutropeniaDr. Schore isExperienced. Learn about Infantile Neutropenia.
- Malignant Peripheral Nerve Sheath TumorDr. Schore isExperienced. Learn about Malignant Peripheral Nerve Sheath Tumor.